Skip to main content

Advertisement

Log in

Radiotherapy for adenoid cystic carcinomas of the head and neck: clinical outcomes and patterns of failure

  • Original Research
  • Published:
Journal of Radiation Oncology

Abstract

Objective

Our goal was to evaluate the use of postoperative or definitive radiotherapy for primary adenoid cystic carcinoma in the head and neck and to determine prognostic variables.

Methods

From April 1973 to June 2009, 44 patients were treated with radiotherapy at Stanford University, 3 definitively and 41 postoperatively.

Results

Median follow-up was 59 months (range, 10–246) for all patients and 56 months for living patients. The median radiation dose was 60 Gy (range, 50–76) with 35 % of patients being treated with IMRT. Five patients (11 %), 1 patient (2 %), and 19 patients (43 %) developed local, regional, and distant failures, respectively. The 5-year and 10-year progression-free and overall survival rates were 57/47 % and 71/59 %, respectively. No patients with negative surgical margins have had a local recurrence. On univariate analysis, residual microscopic and macroscopic disease correlated with progression-free survival (p = 0.048 and p = 0.032, respectively). Residual microscopic disease (p = 0.019), skull base invasion (p = 0.032), and T-classification (p = 0.022) correlated with overall survival. Nine patients experienced acute grade ≥3 toxicity. Eight patients (18 %) developed late grade ≥2 toxicity, including three patients treated with chemoradiotherapy that included a stereotactic boost for gross residual disease, all of whom developed temporal lobe necrosis.

Conclusions

Local control for adenoid cystic carcinoma treated with either postoperative or definitive radiotherapy is excellent. Distant metastasis is the predominant pattern of failure, and treatment failure overall is strongly associated with residual disease status. Stereotactic boosts should be used with caution in patients treated with definitive chemoradiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bradley PJ (2004) Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 12(2):127–132

    Article  PubMed  Google Scholar 

  2. Spiro RH (1986) Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8(3):177–184

    Article  CAS  PubMed  Google Scholar 

  3. Bjorndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, Homoe P, Sorensen CH, Andersen E, Bundgaard T, Primdahl H, Lambertsen K, Andersen LJ, Godballe C (2011) Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 47(7):677–682. doi:10.1016/j.oraloncology.2011.04.020

    Article  PubMed  Google Scholar 

  4. Fitzpatrick PJ, Theriault C (1986) Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 12(10):1743–1747

    Article  CAS  PubMed  Google Scholar 

  5. Chen AM, Garcia J, Lee NY, Bucci MK, Eisele DW (2007) Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67(4):988–994. doi:10.1016/j.ijrobp.2006.10.044

    Article  PubMed  Google Scholar 

  6. Bell D, Hanna EY (2012) Salivary gland cancers: biology and molecular targets for therapy. Current oncology reports 14(2):166–174. doi:10.1007/s11912-012-0220-5

    Article  CAS  PubMed  Google Scholar 

  7. Miglianico L, Eschwege F, Marandas P, Wibault P (1987) Cervico-facial adenoid cystic carcinoma: study of 102 cases. Influence of radiation therapy. Int J Radiat Oncol Biol Phys 13(5):673–678

    Article  CAS  PubMed  Google Scholar 

  8. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW (2006) Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 66(1):152–159. doi:10.1016/j.ijrobp.2006.04.014

    Article  PubMed  Google Scholar 

  9. Silverman DA, Carlson TP, Khuntia D, Bergstrom RT, Saxton J, Esclamado RM (2004) Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck. Laryngoscope 114(7):1194–1199. doi:10.1097/00005537-200407000-00012

    Article  PubMed  Google Scholar 

  10. Gomez DR, Hoppe BS, Wolden SL, Zhung JE, Patel SG, Kraus DH, Shah JP, Ghossein RA, Lee NY (2008) Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 70(5):1365–1372. doi:10.1016/j.ijrobp.2007.08.008

    Article  PubMed  Google Scholar 

  11. Stewart JG, Jackson AW, Chew MK (1968) The role of radiotherapy in the management of malignant tumors of the salivary glands. Am J Roentgenol Radium Ther Nucl Med 102(1):100–108

    Article  CAS  PubMed  Google Scholar 

  12. King JJ, Fletcher GH (1971) Malignant tumors of the major salivary glands. Radiology 100(2):381–384

    CAS  PubMed  Google Scholar 

  13. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ (1995) The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32(3):619–626

    Article  CAS  PubMed  Google Scholar 

  14. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB (2004) Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head and neck 26(2):154–162. doi:10.1002/hed.10380

    Article  PubMed  Google Scholar 

  15. Shen C, Xu T, Huang C, Hu C, He S (2012) Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck. Oral Oncol 48(5):445–449. doi:10.1016/j.oraloncology.2011.12.002

    Article  PubMed  Google Scholar 

  16. Edge SB, American Joint Committee on Cancer, American Cancer Society (2010) AJCC cancer staging handbook: from the AJCC cancer staging manual, 7th edn. Springer, New York

    Book  Google Scholar 

  17. Balamucki CJ, Amdur RJ, Werning JW, Vaysberg M, Morris CG, Kirwan JM, Mendenhall WM (2012) Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol. doi:10.1016/j.amjoto.2011.11.006

    Google Scholar 

  18. National Institute of Mental Health; University of Virginia. Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy (ACCEPT) In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [cited 2012 Sep 4]. Available from: http://clinicaltrials.gov/show/NCT01192087

Download references

Conflicts of interest

Daniel Chang M.D. has received research funding from Varian. Quynh-Thu Le M.D. has received research funding from Varian and Amgen. Otherwise, Drs. Chang and Le have no financial or other relationships which may lead to a conflict of interest.

David B. Shultz, M.D., Ph.D., Youssef H. Zeidan, M.D., Ph.D., James D. Murphy, M.D., M.S., Wendy Hara, M.D., and Michael J. Kaplan, M.D., declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel T. Chang.

Additional information

No human or animal subjects were involved in this retrospective study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shultz, D.B., Zeidan, Y.H., Murphy, J.D. et al. Radiotherapy for adenoid cystic carcinomas of the head and neck: clinical outcomes and patterns of failure. J Radiat Oncol 3, 49–56 (2014). https://doi.org/10.1007/s13566-013-0098-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-013-0098-3

Keywords

Navigation